CompletedNCT00214578
Six months of quetiapine and glucose metabolism in schizophrenia
About this title
Read the official source — NCT00214578Medication studyAges 18–65Multiple countries
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Burgas and 69 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 572
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United Kingdom, Bulgaria, Czechia, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00214578
- Official title
Show the full official title
Seroquel on Glucose Metabolism
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Burgas, Bulgaria · Rousse, Bulgaria · Sofia, Bulgaria
63 more locations
- Sofia- Novi Iskar, Bulgaria
- Varna, Bulgaria
- Dobjany, Czechia
- Dob¿any U Plzn¿, Czechia
- Havlí¿k¿v Brod, Czechia
- Kladno, Czechia
- Miro¿ov, Czechia
- Opava, Czechia
- Pilsen, Czechia
- Prague, Czechia
- Tübingen, Germany
- München, Germany
- Bonn, Germany
- Düsseldorf, Germany
- Münster, Germany
- Magdeburg, Germany
- Berlin, Germany
- Herten, Germany
- Balassagyarmat, Hungary
- Budapest, Hungary
- Cegléd, Hungary
- Debrecen, Hungary
- Eger, Hungary
- Gy¿r, Hungary
- Kaposvár, Hungary
- Kecskemét, Hungary
- Szeged, Hungary
- Szolnok, Hungary
- Bergen, Norway
- Drammen, Norway
- Hagavik, Norway
- Stavanger, Norway
- Stokmarknes, Norway
- Straume, Norway
- Tønsberg, Norway
- Brasov, Romania
- Bucharest, Romania
- Iași, Romania
- Banská Bystrica, Slovakia
- Bojnice, Slovakia
- Bratislava, Slovakia
- Domaša, Slovakia
- Ko¿ice, Slovakia
- Liptovský Mikulá¿, Slovakia
- Michalovce Strá¿any, Slovakia
- Nitra, Slovakia
- Pre¿ov, Slovakia
- Rimavská Sobota, Slovakia
- ¿ilina-Byt¿ica, Slovakia
- ¿ilina, Slovakia
- Medunsa, South Africa
- Bloemfontein, South Africa
- CapeTown, South Africa
- Durban, South Africa
- Ga-Rankuwa, South Africa
- Johannesburg, South Africa
- Krugersdorp, South Africa
- Parktown, South Africa
- Pretoria, South Africa
- Tygerberg, South Africa
- Sutton Coldfield, United Kingdom
- Birmingham, United Kingdom
- Czechia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Did this study involve medication?
Yes. The study involved medication, including Seroquel (quetiapine).
Who was this study for?
Listed age limits: 18 years to 65 years.
